A 43-year-old patient sat down in my consultation room last month and opened with a sentence I have heard hundreds of times: "I almost did not come in. I figured I was too young for this to be a real problem." He had been dealing with intermittent erectile dysfunction for about 18 months. He had tried what most men in his position try — a sildenafil prescription from a telehealth service, an over-the-counter testosterone booster from the supplement aisle, more cardio. None of it worked the way the marketing promised. By the time I saw him, he had convinced himself it was psychological and that he should "just push through it." His labs told a different story.
This is the conversation I want to have publicly, because the men who need it most are the ones least likely to ask. ED in your 40s is not a moral failing, not a sign of decline you have to accept, and not a problem that resolves itself. It is a clinical signal — usually pointing to something specific and treatable underneath.
Why the 40s are the inflection point
In my practice I see a clear pattern. Symptoms typically begin between 38 and 45, get explained away as stress or a bad week, and persist for two to four years before the patient brings them up to a clinician. By the time we are talking about it, the underlying physiology has usually drifted far enough that several systems are involved.
There is a reason that decade matters. Total testosterone in men declines roughly 1 to 2 percent per year starting in the early 30s. SHBG climbs slowly across the same window, which means free testosterone — the fraction that actually does the work at the receptor — drops faster than total testosterone. Endothelial function in the smaller arteries (including the cavernosal arteries that supply erectile tissue) starts showing measurable decline a decade or more before the changes show up on a stress test. Insulin sensitivity quietly worsens, especially in men who have added 15 to 25 pounds of visceral weight since their 20s.
None of these shifts produces a dramatic symptom on its own. They produce a slow erosion of function that the patient blames on stress, age, alcohol, or his marriage. Then one of those background factors tips the system, and the symptom becomes hard to ignore.
What is actually happening physiologically
An erection is a vascular event triggered by a neurological signal in a hormonally permissive environment. All three layers have to work. When I evaluate someone for ED, I am asking which of those three is failing — and usually the honest answer is more than one.
The vascular layer matters disproportionately in the 40s patient. The penile arteries are roughly 1 to 2 mm in diameter; the coronary arteries are 3 to 4 mm. Endothelial dysfunction shows up in the smaller vessels first. From a cardiology perspective — and this is where my background in the cardiac ICU and cath lab still shapes how I think — new-onset ED in a man in his 40s is one of the earliest clinical markers of cardiovascular disease. It often precedes a documented coronary event by three to five years. Treating the symptom without working up the vasculature is a missed opportunity at best and clinically negligent at worst.
The hormonal layer is the one most patients have heard about, and the one most often mishandled. Total testosterone alone is not a sufficient evaluation. I look at total testosterone, free testosterone, SHBG, estradiol (sensitive assay), LH, FSH, and prolactin together — because the ratios tell the story the single number does not. A man with a "normal" total testosterone of 450 ng/dL but elevated SHBG and a free testosterone in the bottom 10 percent of the range is functionally hypogonadal. He will be told his labs are fine and sent home. They are not fine.
The neurological and tissue-quality layer is what regenerative treatments target. Chronic vascular insufficiency causes microscopic fibrosis in the corporal tissue over time. That fibrosis does not respond to a PDE-5 inhibitor — there is nothing left for the medication to act on. This is where the O-Shot and PRP-based protocols for men have a clinical role: not as a first-line cosmetic upgrade, but as a way to address tissue quality in patients whose other layers are already being optimized.
What I look for in the workup
When a 40s patient comes in for ED treatment, the first visit is conversation and history. The second visit is data. I want to know:
- Onset pattern. Sudden onset usually means a discrete event — a new medication, a major stressor, a vascular event. Gradual onset over a year or more usually means a slow physiological drift.
- Situational variation. Morning erections present? Erections with self-stimulation but not with a partner? These are not trick questions; they help separate vascular from neurological from psychological contributors.
- Medication audit. SSRIs, beta-blockers, finasteride, certain antihistamines, PPIs, and a long list of common prescriptions suppress sexual function. I review every prescription and supplement, because the answer is sometimes "stop the medication that is causing the problem" rather than "add another one."
- Cardiovascular workup. Lipid panel with apolipoprotein B, hs-CRP, fasting glucose, fasting insulin, HbA1c, blood pressure pattern. If the cardiovascular picture is concerning, that gets addressed in parallel — not deferred.
- Hormonal panel. The full panel above, drawn before 10 AM, fasting, on a day the patient has not had an unusual amount of stress or sleep deprivation. One outlier draw is not a diagnosis.
What I am building is a picture, not a single number. The treatment plan follows from the picture.
Not sure where to start?
The Start Here pathway walks you through the most common entry points and helps you decide which consultation type is the right fit. Five minutes of self-assessment can save you a wrong-direction conversation.
Why the conventional approaches usually fall short
Most men in their 40s who walk into my office have already tried one or two things. The pattern is predictable and the results are predictable.
A telehealth sildenafil prescription works for some men and not others. It addresses one downstream mechanism — PDE-5 inhibition — without touching the vascular, hormonal, or tissue layers underneath. When it works, it works because the underlying machinery is still mostly intact and the medication is enough to push the patient over the threshold. When it does not work, it does not work because something more fundamental is wrong, and adding a higher dose of the same medication will not fix that.
The supplement aisle is a different problem. The "testosterone boosters" sold over the counter do not raise testosterone in any meaningful way in men with documented hypogonadism. They are not a substitute for clinical hormone optimization or men's hormone therapy when the labs support it. When a patient tells me he has been on a supplement stack for six months and feels no different, I am not surprised — and I do not blame him for trying, because the marketing is genuinely good.
The "just lose weight and exercise" advice is correct in spirit and useless in execution for most men in this group. Weight loss in an insulin-resistant 45-year-old with a free testosterone in the basement does not work the same way it does in a 25-year-old with intact metabolism. The hormonal correction often has to come first, or the weight loss cannot get traction.
How treatment actually gets built
The plan follows the workup. There is no template I apply to every patient — there are categories that show up repeatedly, and within each category the dosing and sequencing are individualized.
If the dominant contributor is hormonal, hormone optimization comes first. I dose conservatively, recheck labs at 6 weeks and 12 weeks, and titrate based on response — not based on a target number on a lab report. The goal is the patient feeling and functioning well, with labs that make physiological sense.
If the dominant contributor is vascular, the cardiovascular workup drives the plan. That sometimes means a referral to cardiology if the picture warrants it. It always means addressing lipids, glucose regulation, and blood pressure with the seriousness those findings deserve. Sexual function is often the first thing that improves when the vascular picture is corrected — sometimes before the patient notices any other change.
If tissue quality is the limiting factor — usually in patients with longstanding ED, diabetic patients, or post-prostatectomy patients — regenerative options including PRP-based protocols become part of the conversation. These are not first-line for every patient. They are appropriate when the workup says they are appropriate.
In most 40s patients, the answer is some combination of the three, sequenced and dosed based on what the data shows. A coordinated plan works. A single-lever pull rarely does.
A specific clinical next step
If you have been sitting on this for months or years, the most useful thing you can do is stop trying to figure it out alone and bring the question to someone who will actually work it up. That means a comprehensive workup before any treatment recommendation — not a 12-minute telehealth visit, not a supplement stack, not another round of guessing.
Book a private consultation at the Columbus consultation location or Warner Robins. Bring any lab work you have from the past 12 months, a full list of your current medications and supplements, and a written description of when the symptoms started and how they have changed. The first visit is the history and the lab order; the second is the data review and the plan. By the second visit, you and I will be looking at the same picture and deciding together what the first move should be.
The men who do best in my practice are the ones who treated this the way they would treat any other clinical signal — early, with data, and without pretending it was not there.
Medical disclaimer: This article is for educational purposes only and does not constitute medical advice. Individual clinical decisions should be made in consultation with a qualified healthcare provider following appropriate evaluation. References to specific treatments, dosing, or protocols are informational.
Travis spent 17+ years in high-acuity clinical medicine — emergency, cardiac ICU, and cath lab — before founding Revitalize. He is a Certified Platinum Biote hormone therapy provider, the published author of You're Not Broken — You're Unbalanced, and the founder of the Rebuild Metabolic Health Institute. His clinical writing reflects the same precision he brought to critical care: specific, honest, and built around what actually works.
Ready to talk it through with a clinician?
Book online or call either Georgia location. Every visit starts with a consultation.